Several researches showed that CCNB2 overexpression was associated with poor prognosis in human hepatocellular carcinoma, non-small cell lung cancer patients and invasive breast carcinoma (Shubbar et al., 2013; Qian et al., 2015; Li et al., 2019). The gene discussed is CCNB2; the disease is non-small cell lung carcinoma.